- Home
- GOSS vs MMU Comparison
GOSS vs MMU Comparison
Compare GOSS & MMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- MMU
- Stock Information
- Founded
- GOSS 2015
- MMU 1992
- Country
- GOSS United States
- MMU United States
- Employees
- GOSS N/A
- MMU N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- MMU Investment Managers
- Sector
- GOSS Health Care
- MMU Finance
- Exchange
- GOSS Nasdaq
- MMU Nasdaq
- Market Cap
- GOSS 501.2M
- MMU 568.0M
- IPO Year
- GOSS 2019
- MMU N/A
- Fundamental
- Price
- GOSS $2.37
- MMU $10.30
- Analyst Decision
- GOSS Strong Buy
- MMU
- Analyst Count
- GOSS 6
- MMU 0
- Target Price
- GOSS $8.60
- MMU N/A
- AVG Volume (30 Days)
- GOSS 3.0M
- MMU 170.7K
- Earning Date
- GOSS 11-05-2025
- MMU 01-01-0001
- Dividend Yield
- GOSS N/A
- MMU 4.92%
- EPS Growth
- GOSS N/A
- MMU N/A
- EPS
- GOSS N/A
- MMU N/A
- Revenue
- GOSS $40,237,000.00
- MMU N/A
- Revenue This Year
- GOSS N/A
- MMU N/A
- Revenue Next Year
- GOSS $16.11
- MMU N/A
- P/E Ratio
- GOSS N/A
- MMU N/A
- Revenue Growth
- GOSS N/A
- MMU N/A
- 52 Week Low
- GOSS $0.66
- MMU $8.60
- 52 Week High
- GOSS $3.60
- MMU $10.45
- Technical
- Relative Strength Index (RSI)
- GOSS 48.07
- MMU 44.37
- Support Level
- GOSS $2.28
- MMU $10.25
- Resistance Level
- GOSS $2.52
- MMU $10.35
- Average True Range (ATR)
- GOSS 0.15
- MMU 0.07
- MACD
- GOSS 0.02
- MMU -0.02
- Stochastic Oscillator
- GOSS 62.79
- MMU 25.58
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).